Document is current
Any future updates will be listed below
-
Authors
Pagliaccio, David https://orcid.org/0000-0002-1214-1965
Wengler, Kenneth https://orcid.org/0000-0002-8153-5183
Durham, Katherine
Fontaine, Martine
Rueppel, Meryl
Becker, Hannah
Bilek, Emily
Pieper, Sarah
Risdon, Caroline
Horga, Guillermo
Fitzgerald, Kate D.
Marsh, Rachel https://orcid.org/0000-0003-2439-6305
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126181, R21 MH125044, F32 MH125540, R01 MH117323, R01 MH114965, R01 MH115024, R01 MH115024)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 9 January 2023
Revised: 26 April 2023
Accepted: 3 May 2023
First Online: 17 May 2023
Competing interests
: KW and GH report having filed patents for analysis and use of neuromelanin imaging in central nervous system disorders, licensed to Terran Biosciences, but have received no royalties. All other authors reported no biomedical financial interests or potential conflicts of interest.
